ETHK Labs Inc 01931
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HK$0.36
- Day Range
- HK$0.36–0.36
- 52-Week Range
- HK$0.35–9.98
- Bid/Ask
- HK$0.36 / HK$0.40
- Shares Outstanding
- 1.60B
- Market Cap
- HK$568.56M
- Volume/Avg
- 60,000 / 280,891
Key Statistics
- Price/Earnings (Normalized)
- 9.63
- Price/Sales
- 0.18
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 18.24%
Company Profile
ETHK Labs Inc is engaged in the distribution, after-sales service, and development of in-vitro diagnostic (IVD) products in China. The company operates through three business segments: Distribution Business, After-sales Services, and Self-branded Products Business. It distributes IVD analysers, reagents, and consumables to hospitals and healthcare institutions, provides maintenance and installation services for diagnostic equipment, and develops and sells self-branded IVD analysers and reagents. The company generates the majority of its revenue from Mainland China.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Value
- Total Number of Employees
- 4,386
- Website
- https://www.ethk.com
Valuation
|
Metric
|
01931
|
|---|---|
Price/Earnings (Normalized) | 9.63 |
Price/Book Value | 0.18 |
Price/Sales | 0.18 |
Price/Cash Flow | 0.87 |
Price/Earnings
01931
Financial Strength
|
Metric
|
01931
|
|---|---|
Quick Ratio | 0.70 |
Current Ratio | 1.56 |
Interest Coverage | −0.60 |
Quick Ratio
01931
Profitability
|
Metric
|
01931
|
|---|---|
Return on Assets (Normalized) | −0.62% |
Return on Equity (Normalized) | −1.83% |
Return on Invested Capital (Normalized) | 0.49% |
Return on Assets
01931
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|snGfzf^ | LOCK|J@wt | $109B | |||
| Cencora Inc
COR
| LOCK|qnLMfz? | LOCK|&&&l | $62B | |||
| Cardinal Health Inc
CAH
| LOCK|g&g&w^n | LOCK|>&bW | $55B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|X>qx | $22B | |||
| Henry Schein Inc
HSIC
| LOCK|x@&zXqf | LOCK|RS$FR | $9B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
| — | LOCK|<Fx | $8B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|XP | $6B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|@? | $6B | |||
| Galenica Ltd
GALNF
| — | LOCK|$#N# | $5B | |||
| Medipal Holdings Corp
MEPDF
| — | LOCK|%#j | $4B |
United States